Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Price of 1000 plus...

    Price of 1000 plus essential medicines capped by Government: Ministers inform Parliament

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-22T15:13:53+05:30  |  Updated On 16 Aug 2021 11:49 AM GMT

    The parliament was also apprised about the details of drugs under the list of Essential Medicines, as included in the National List of Essential Medicines (NLEM), 2015, available on the website of Central Drugs Standard Control Organization (CDSCO).


    New Delhi: The price of 1032 essential medicines have been capped by the government to help provide poor medicines at cheaper rates, the Rajya Sabha was informed recently.


    The parliament was also apprised about the details of drugs under the list of Essential Medicines, as included in the National List of Essential Medicines (NLEM), 2015, available on the website of Central Drugs Standard Control Organization (CDSCO) i.e. www.cdsco.gov.in. The NLEM, 2015 includes 376 medicines. Subsequently, coronary stents were included in the list in 2016.


    As per the World Health Organization (WHO), essential medicines are those that satisfy the priority health care needs of the population. The list is made with consideration to disease prevalence, efficacy, safety and comparative cost-effectiveness of the medicines.


    In India, the NLEM is prepared by the Ministry of Health & Family Welfare (M/o H&FW). The criteria adopted by the Core Committee constituted by M/o H&FW for preparation of NLEM, 2015 for the inclusion of a medicine in NLEM, 2015 were as follows-


    (i) The medicine should be approved/licensed in India.
    (ii) The medicine should be useful in preventing/treatment of a disease which is a public health problem in India.
    (iii) The medicine should have proven efficacy and safety profile based on valid scientific evidence.
    (iv) The medicine should be comparatively cost effective.
    (v) The medicine should be aligned with the current treatment guidelines for the disease.
    (vi) The medicine should be stable under the storage conditions in India.
    (vii) Medicines recommended under National Health Programmes of India.
    (viii) When more than one medicine is available from the same therapeutic class, preferably one prototype/ medically best-suited medicine of that class to be included after due deliberation and careful evaluation of their relative safety, efficacy and cost-effectiveness.
    (ix) Price of total treatment to be considered and not the unit price of a medicine.
    (x) FDC is not included unless the combination has unequivocally proven advantages over single compounds administered separately, in terms of increasing efficacy, reducing adverse effects and/or improving compliance.
    (xi) The medicine in NLEM will be based at Primary, Secondary and Tertiary (P/S/T) levels of health care according to treatment facilities and training, experience and availability of health care personnel at these levels.


    "As could be seen from the criteria mentioned above, cost-effectiveness, and not high-market price, of a medicine was a criterion for it to be included in NLEM," reads D V Sadananda Gowda's response to a query regarding the list of essential medicines.


    "A Standing National Committee on Medicines (SNCM) has been constituted by the Ministry of Health & Family Welfare in July, 2018 to review and revise the National list of Essential Medicines (NLEM) by way of additions and deletions in the existing NLEM in the context of contemporary knowledge of use of therapeutic products in health & hygiene of general public," he added while replying to the questions.

    https://pubads.g.doubleclick.net/gampad/ads?iu=/21687779244/clinicalkey_video_ad&description_url=[placeholder]&tfcd=0&npa=0&sz=640x480&gdfp_req=1&output=vast&unviewed_position_start=1&env=vp&impl=s&correlator=

    Minister of State for Chemicals and Fertilisers Mansukhlal Mandavia said the government is attempting to provide 700 drugs in Jan Aushadi Stores and a total of 20 truck-loads of medicines are being supplied to such stores per day for providing drugs at cheaper rates to the poor.


    He said Jan Aushadhi stores are opened with an aim of providing quality and affordable drugs to the poor.


    Also Read: HC Rescues Lupin on Price cap on powdered form of asthma drug


    Mandavia, while replying to questions, said the government has fixed trade margins of 42 medicines relating to cancer and other diseases, which has helped bring down their price by 90 per cent.


    "A total of 526 formulations are now available at 90 per cent less rates than the market after the government has taken this initiative of fixing trade margins," the minister said.


    Asked about any checks on pharma producers selling such drugs at higher rates, the minister said, the National Pharma Pricing Authority (NPPA) has been set up by the government and is looking into whether anyone is selling drugs at higher prices, reports PTI.


    Also Read: Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

    affordable medicines CDSCO Chemicals and Fertilisers drug price drug price cap essential medicines FDC formulations Jan Aushadi Jan Aushadi stores Mansukhlal Mandavia medicines Ministry of Chemicals and Fertilisers National Pharma Pricing Authority NLEM NPPA pharma pharma news pharma news india Pharmaceutical industry Rajya Sabha trade margin www.cdsco.gov.in 
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X